X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2097) 2097
Book Review (296) 296
Publication (82) 82
Conference Proceeding (9) 9
Book Chapter (5) 5
Dissertation (2) 2
Newspaper Article (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1861) 1861
humans (1196) 1196
male (1027) 1027
dihydropyridines - therapeutic use (957) 957
animals (845) 845
calcium channel blockers - therapeutic use (769) 769
pharmacology & pharmacy (758) 758
hypertension - drug therapy (708) 708
female (665) 665
dihydropyridines - pharmacology (614) 614
middle aged (515) 515
calcium channel blockers - pharmacology (476) 476
blood pressure - drug effects (452) 452
rats (440) 440
aged (426) 426
hypertension (419) 419
antihypertensive agents - therapeutic use (415) 415
dihydropyridine (336) 336
adult (309) 309
hypertension - physiopathology (259) 259
dihydropyridines (219) 219
peripheral vascular disease (215) 215
nifedipine (202) 202
dihydropyridines - adverse effects (199) 199
amlodipine (194) 194
mice (186) 186
dihydropyridines - administration & dosage (185) 185
calcium channel blockers - adverse effects (184) 184
cardiac & cardiovascular systems (183) 183
treatment outcome (181) 181
dose-response relationship, drug (174) 174
dihydropyridines - chemistry (173) 173
drug therapy, combination (168) 168
heart rate - drug effects (168) 168
blood-pressure (164) 164
hypertension - complications (164) 164
calcium channel blockers (148) 148
calcium channels (144) 144
double-blind method (143) 143
calcium (134) 134
calcium channel blockers - administration & dosage (132) 132
chemistry, medicinal (129) 129
antagonists (123) 123
in vitro techniques (120) 120
antihypertensive agents - adverse effects (118) 118
amlodipine - therapeutic use (117) 117
antihypertensive agents - pharmacology (115) 115
lacidipine (113) 113
blood pressure (112) 112
analysis (111) 111
calcium - metabolism (108) 108
rats, wistar (108) 108
biochemistry & molecular biology (104) 104
time factors (100) 100
azetidinecarboxylic acid - analogs & derivatives (99) 99
angiotensin-converting enzyme inhibitors - therapeutic use (98) 98
calcium antagonists (98) 98
aged, 80 and over (97) 97
hemodynamics - drug effects (97) 97
nifedipine - therapeutic use (97) 97
calcium channel blocker (96) 96
disease models, animal (96) 96
neurosciences (96) 96
isradipine (92) 92
nifedipine - pharmacology (91) 91
lercanidipine (89) 89
dihydropyridines - pharmacokinetics (88) 88
prospective studies (86) 86
nimodipine (85) 85
rats, inbred shr (85) 85
drug therapy (82) 82
pharmacology/toxicology (82) 82
antihypertensive agents - administration & dosage (76) 76
azetidinecarboxylic acid - therapeutic use (75) 75
abridged index medicus (74) 74
drugs (73) 73
medicine & public health (73) 73
disease (72) 72
mortality (72) 72
oxidative stress (72) 72
dogs (71) 71
rats, sprague-dawley (71) 71
calcium channel blockers - chemistry (70) 70
research (70) 70
structure-activity relationship (70) 70
dihydropyridines - metabolism (69) 69
toxicology (69) 69
ca2+ channels (68) 68
calcium channel blockers - pharmacokinetics (68) 68
calcium channels - drug effects (68) 68
cells (68) 68
cells, cultured (66) 66
antihypertensive drugs (65) 65
blood pressure - physiology (65) 65
inhibition (65) 65
rabbits (65) 65
risk factors (65) 65
verapamil (65) 65
cilnidipine (64) 64
angiotensin ii type 1 receptor blockers - therapeutic use (63) 63
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1978) 1978
Russian (31) 31
Japanese (29) 29
German (21) 21
French (15) 15
Chinese (8) 8
Italian (7) 7
Spanish (6) 6
Portuguese (4) 4
Ukrainian (3) 3
Czech (2) 2
Croatian (1) 1
Danish (1) 1
Dutch (1) 1
Finnish (1) 1
Hebrew (1) 1
Hungarian (1) 1
Polish (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Hypertension, ISSN 0194-911X, 10/2009, Volume 54, Issue 4, pp. 716 - 723
The aim of this study was to compare the effects between calcium channel blockers and diuretics when used in combination with angiotensin II receptor blocker... 
Ambulatory blood pressure | Pulse wave velocity | Central blood pressure | Angiotensin II receptor blocker | Thiazide diuretic | Calcium channel blocker | thiazide diuretic | PULSE-WAVE VELOCITY | AZELNIDIPINE | CARDIOVASCULAR EVENTS | pulse wave velocity | RANDOMIZED TRIAL | ATENOLOL | AMLODIPINE | REDUCTION | central blood pressure | calcium channel blocker | angiotensin II receptor blocker | PERIPHERAL VASCULAR DISEASE | ambulatory blood pressure | ANTIHYPERTENSIVE THERAPY | HEART-RATE | CENTRAL BLOOD-PRESSURE | Single-Blind Method | Prospective Studies | Tetrazoles - pharmacology | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Male | Azetidinecarboxylic Acid - analogs & derivatives | Angiotensin II Type 1 Receptor Blockers - pharmacology | Azetidinecarboxylic Acid - therapeutic use | Time Factors | Hydrochlorothiazide - pharmacology | Azetidinecarboxylic Acid - pharmacology | Female | Blood Pressure - drug effects | Aorta - physiopathology | Imidazoles - therapeutic use | Drug Therapy, Combination | Diuretics - pharmacology | Japan | Treatment Outcome | Imidazoles - pharmacology | Calcium Channel Blockers - pharmacology | Hypertension - physiopathology | Dihydropyridines - therapeutic use | Dihydropyridines - pharmacology | Diuretics - therapeutic use | Tetrazoles - therapeutic use | Aged | Hydrochlorothiazide - therapeutic use | Index Medicus
Journal Article
Journal Article
Hypertension, ISSN 0194-911X, 06/2012, Volume 59, Issue 6, pp. 1132 - 1138
Journal Article
European Journal of Haematology, ISSN 0902-4441, 06/2012, Volume 88, Issue 6, pp. 535 - 548
Objectives:  Iron‐overload cardiomyopathy is a major cause of morbidity and mortality in patients with thalassemia. However, the precise mechanisms of iron... 
calcium channel | iron overload | cardiac iron | left ventricular function | heart rate variability | Iron overload | Cardiac iron | Calcium channel | Heart rate variability | Left ventricular function | MALONDIALDEHYDE | QUANTIFICATION | CA2+ CHANNELS | CARDIAC MYOCYTES | RATS | CARDIOMYOCYTES | TRANSFERRIN-BOUND IRON | HEART-RATE-VARIABILITY | IRON-OVERLOAD CARDIOMYOPATHY | HEMATOLOGY | EXPRESSION | beta-Thalassemia - pathology | Humans | Calcium Channel Blockers - therapeutic use | beta-Thalassemia - genetics | Deferoxamine - therapeutic use | Azoles - therapeutic use | DNA Primers - genetics | Iron, Dietary - administration & dosage | RNA, Messenger - metabolism | Cardiovascular System - physiopathology | Verapamil - therapeutic use | Base Sequence | Nifedipine - therapeutic use | Nitrophenols - therapeutic use | Calcium Channels, T-Type - genetics | Organoselenium Compounds - therapeutic use | Disease Models, Animal | Iron - blood | Heart Rate | Iron Chelating Agents - therapeutic use | Mice, Inbred C57BL | RNA, Messenger - genetics | Ventricular Function, Left - drug effects | Organophosphorus Compounds - therapeutic use | beta-Thalassemia - physiopathology | Cardiovascular System - drug effects | Iron - metabolism | Mice, Knockout | Dihydropyridines - therapeutic use | beta-Thalassemia - drug therapy | Organ Size - drug effects | Animals | Calcium Channels, L-Type - genetics | Calcium Channels, L-Type - drug effects | Calcium Channels, T-Type - drug effects | Mice | Index Medicus
Journal Article
Circulation, ISSN 0009-7322, 07/2012, Volume 126, Issue 5, pp. 569 - 578
Background-In high-cardiovascular-risk treated hypertensive patients, the incidence of cardiovascular events has been reported to relate to visit-to-visit... 
risk factors | carotid intima-media thickness | hypertension | BP variability | INTIMA-MEDIA THICKNESS | SYSTOLIC HYPERTENSION | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | MYOCARDIAL-INFARCTION | ARTERY INTIMA | OLDER-ADULTS | RISK | PROGNOSTIC VALUE | MEASURING DEVICES | PERIPHERAL VASCULAR DISEASE | ANTIHYPERTENSIVE TREATMENT | Antihypertensive Agents - pharmacology | Prognosis | Prospective Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Male | Incidence | Carotid Artery Diseases - diagnostic imaging | Adrenergic Antagonists - therapeutic use | Female | Blood Pressure - drug effects | Blood Pressure - physiology | Hypertension - diagnosis | Atenolol - pharmacology | Double-Blind Method | Office Visits | Carotid Intima-Media Thickness | Europe | Carotid Artery Diseases - epidemiology | Treatment Outcome | Circadian Rhythm - physiology | Antihypertensive Agents - therapeutic use | Calcium Channel Blockers - pharmacology | Hypertension - physiopathology | Adrenergic Antagonists - pharmacology | Dihydropyridines - therapeutic use | Atenolol - therapeutic use | Dihydropyridines - pharmacology | Aged | Hypertension | Measurement | Care and treatment | Patient outcomes | Atherosclerosis | Blood pressure | Research | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2012, Volume 125, Issue 10, pp. 981 - 990
Abstract Background It is unknown whether high-dose angiotensin II receptor blocker therapy or angiotensin II receptor blocker + calcium channel blocker... 
Internal Medicine | Hypertension | Type 2 diabetes | Clinical trials | Cardiovascular disease | Combination therapy | High-dose angiotensin II receptor blocker | Elderly | CALCIUM-CHANNEL BLOCKER | OLMESARTAN MEDOXOMIL | MONOTHERAPY | AZELNIDIPINE | RANDOMIZED-TRIAL | BLOOD-PRESSURE | AMLODIPINE | MEDICINE, GENERAL & INTERNAL | DOUBLE-BLIND | VALSARTAN | Single-Blind Method | Prospective Studies | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Male | Azetidinecarboxylic Acid - analogs & derivatives | Cardiovascular Diseases - complications | Azetidinecarboxylic Acid - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - mortality | Female | Hypertension - mortality | Imidazoles - therapeutic use | Drug Therapy, Combination | Diabetes Mellitus, Type 2 - complications | Drug Administration Schedule | Japan | Treatment Outcome | Amlodipine - therapeutic use | Dihydropyridines - therapeutic use | Survival Analysis | Hypertension - complications | Tetrazoles - therapeutic use | Aged | Prevention | Safety and security measures | Demographic aspects | Angiotensin II receptor blockers | Dosage and administration | Research | Drug therapy, Combination | Drug therapy | Cardiovascular diseases | Older people | Medical treatment | Asians | Index Medicus | Abridged Index Medicus | Calcium | Diabetes mellitus | Mortality | Blood pressure
Journal Article
Journal Article